BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 18838329)

  • 21. [Scleroderma, dermatomyositis].
    Yamakage A
    Nihon Rinsho; 1994 Aug; 52(8):2114-9. PubMed ID: 7933595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A role for lysophosphatidic acid and sphingosine 1-phosphate in the pathogenesis of systemic sclerosis.
    Pattanaik D; Postlethwaite AE
    Discov Med; 2010 Aug; 10(51):161-7. PubMed ID: 20807477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Scleroderma and related conditions.
    Mitchell H; Bolster MB; LeRoy EC
    Med Clin North Am; 1997 Jan; 81(1):129-49. PubMed ID: 9012758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis.
    LeRoy EC; Black C; Fleischmajer R; Jablonska S; Krieg T; Medsger TA; Rowell N; Wollheim F
    J Rheumatol; 1988 Feb; 15(2):202-5. PubMed ID: 3361530
    [No Abstract]   [Full Text] [Related]  

  • 25. Localized and systemic scleroderma.
    Hawk A; English JC
    Semin Cutan Med Surg; 2001 Mar; 20(1):27-37. PubMed ID: 11308134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. One year in review 2019: systemic sclerosis.
    Barsotti S; Orlandi M; Codullo V; Di Battista M; Lepri G; Della Rossa A; Guiducci S
    Clin Exp Rheumatol; 2019; 37 Suppl 119(4):3-14. PubMed ID: 31587697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathogenesis and staging of scleroderma.
    Winkelmann RK
    Acta Derm Venereol; 1976; 56(2):83-92. PubMed ID: 58529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathogenesis of progressive systemic sclerosis.
    Haustein UF; Herrmann K; Böhme HJ
    Int J Dermatol; 1986 Jun; 25(5):286-93. PubMed ID: 3522447
    [No Abstract]   [Full Text] [Related]  

  • 29. Systemic sclerosis sine scleroderma.
    Kucharz EJ; Kopeć-Mędrek M
    Adv Clin Exp Med; 2017 Aug; 26(5):875-880. PubMed ID: 29068586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The IL-1 family of cytokines. Do they have a role in scleroderma fibrosis?
    Artlett CM
    Immunol Lett; 2018 Mar; 195():30-37. PubMed ID: 29203183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Scleroderma - new aspects in pathogenesis and treatment.
    Balbir-Gurman A; Braun-Moscovici Y
    Best Pract Res Clin Rheumatol; 2012 Feb; 26(1):13-24. PubMed ID: 22424190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Systemic sclerosis--clinical course and treatment possibilities].
    Szymańska E; Maj M; Rudnicka L
    Przegl Lek; 2005; 62(12):1538-41. PubMed ID: 16786791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dermal dendritic cell population and blood vessels are diminished in the skin of systemic sclerosis patients: relationship with fibrosis degree and disease duration.
    de-Sá-Earp AP; do Nascimento AP; Carneiro SC; Porto LC; Monte-Alto-Costa A
    Am J Dermatopathol; 2013 Jun; 35(4):438-44. PubMed ID: 23262669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human adipose mesenchymal stem cells as potent anti-fibrosis therapy for systemic sclerosis.
    Maria AT; Toupet K; Maumus M; Fonteneau G; Le Quellec A; Jorgensen C; Guilpain P; Noël D
    J Autoimmun; 2016 Jun; 70():31-9. PubMed ID: 27052182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improvement in skin thickening in systemic sclerosis associated with improved survival.
    Steen VD; Medsger TA
    Arthritis Rheum; 2001 Dec; 44(12):2828-35. PubMed ID: 11762943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An update on biomarker discovery and use in systemic sclerosis.
    Matsushita T; Takehara K
    Expert Rev Mol Diagn; 2017 Sep; 17(9):823-833. PubMed ID: 28730919
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Systemic sclerosis--pathogenesis, clinical manifestations and treatment].
    Radić M; Kaliterna DM; Fabijanić D; Radić J
    Lijec Vjesn; 2010; 132(5-6):162-8. PubMed ID: 20677623
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biomedical research. More than skin deep.
    Cahoon L
    Science; 2008 Oct; 322(5902):667-9. PubMed ID: 18974325
    [No Abstract]   [Full Text] [Related]  

  • 39. [Scleroderma: an update on the pathogenesis and treatment].
    Garza-Rodríguez V; Villarreal-Alarcón MA; Ocampo-Candiani J
    Rev Med Inst Mex Seguro Soc; 2013; 51(1):50-7. PubMed ID: 23550408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systemic sclerosis: An update in 2016.
    Desbois AC; Cacoub P
    Autoimmun Rev; 2016 May; 15(5):417-26. PubMed ID: 26802722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.